| 000 | 01546 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516055111.0 | ||
| 264 | 0 | _c20120223 | |
| 008 | 201202s 0 0 tur d | ||
| 022 | _a0374-9096 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYenigün Koçak, Bahar | |
| 245 | 0 | 0 |
_a[Evaluation of epidemiological characteristics and risk factors of candidemia in adult patients in a tertiary-care hospital]. _h[electronic resource] |
| 260 |
_bMikrobiyoloji bulteni _cJul 2011 |
||
| 300 |
_a489-503 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntifungal Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCandidemia _xdrug therapy |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCatheterization, Central Venous _xadverse effects |
| 650 | 0 | 4 |
_aCross Infection _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluconazole _xadministration & dosage |
| 650 | 0 | 4 | _aHospital Mortality |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aIntensive Care Units |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTurkey _xepidemiology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aKuloğlu, Figen | |
| 700 | 1 | _aDoğan Çelik, Aygül | |
| 700 | 1 | _aAkata, Filiz | |
| 773 | 0 |
_tMikrobiyoloji bulteni _gvol. 45 _gno. 3 _gp. 489-503 |
|
| 999 |
_c21173991 _d21173991 |
||